Related Experiment Video
Updated: Oct 30, 2025
10:15
Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation
Published on: April 13, 2017
8.1K
Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring
Natalia Teresa Jarzebska1,2, Julia Frei1,3, Severin Lauchli1,3
1Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Raemistrasse 100, 8091 Zürich, Switzerland.
Viruses
|July 2, 2021
Summary
Quantifying T-cell immune responses is vital. This study introduces a simple lipofection method using synthetic mRNA for rapid in vitro T-cell response assessment, aiding immunity monitoring and immunotherapy validation.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Quantifying T-cell immune responses is essential for monitoring immunity and validating immunotherapies.
- Current methods for T-cell response assessment can be complex and time-consuming.
Purpose of the Study:
- To develop a simple and rapid method for in vitro T-cell response quantification.
- To evaluate the efficacy of lipofection of synthetic mRNA in mononuclear cells for T-cell immunomonitoring.
Main Methods:
- Comparison of commercially available transfection reagents for mRNA delivery into human peripheral blood mononuclear cells and murine splenocytes.
- Investigation of RNA modifications to enhance transfection efficiency and T-cell stimulation.
- Assessment of antigen-specific T-cell responses following mRNA lipofection.
Main Results:
- Lipofection of synthetic mRNA provides a straightforward method for in vitro T-cell response determination.
- Successful transfection of mRNA into complex immune cell populations was achieved.
- Antigen-specific T-cell immunomonitoring was demonstrated to be rapid and efficient using this approach.
Conclusions:
- This lipofection-based method offers a convenient solution for in vitro monitoring of T-cell immune responses.
- The technique is applicable for assessing both natural and treatment-induced immunity.
- The findings support the use of this method for validating novel immunotherapeutic strategies.
